This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Covalon To Showcase New Wound Healing And Infection Management Products At MEDICA

TORONTO, Nov. 19, 2013 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, will showcase new products at MEDICA the world's largest medical technology trade fair, November 20 to 23 in Düsseldorf, Germany.

Brian Pedlar, Covalon's Chief Executive Officer said, "Since we announced the transformative license agreement with Molnlycke earlier this month, the amount of interest in our new product pipeline has spiked significantly.  As a result, we have accelerated the unveiling of our FDA-cleared ColActive ® Transfer wound dressing and our CovaCoat™ A.I. Anti Infective coatings.  Along with our proven ColActive ® Plus wound dressings and SilverCoat™ Antimicrobial Foley Catheters, our strong pipeline of new products and technologies, which includes ColActive ® Transfer and CovaCoat™ A.I., positions Covalon well as a partner for wound care, urological, vascular access, surgical and orthopaedic companies and distributors."

The latest addition to the patented ColActive™ family of wound care products being showcased at MEDICA is ColActive ® Transfer, Covalon's bio-degradable wound dressing that stimulates wound healing responses in difficult to heal wounds, while allowing wound fluids to pass through the dressing.  ColActive ® Transfer is designed to protect new-growth tissue in wounds undergoing treatment and is FDA approved for sale in the United States.  Along with the introduction of ColActive ® Transfer, Covalon anticipates entering the nearly US$500 million negative pressure dressing and kit market.

Covalon will also be unveiling its new patented CovaCoat™ A.I. Anti Infective coating technology that provides antimicrobial and anti-thrombogenic properties, without eluting antimicrobial agents from the surface of medical devices. Covalon's CovaCoat™ A.I. Anti Infective Foley Catheter significantly reduces biofilm formation on urinary catheters, the formation of which is a major source of hospital acquired infections.  The use of CovaCoat™ A.I. on vascular access devices provides both anti-thrombogenic and antimicrobial characteristics without the downside of delivering potentially cytotoxic antimicrobial agents directly into the bloodstream.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs